Contact
searchSearch
HMP Global

Advertisement

Advertisement

ADVERTISEMENT

Psoriatic Arthritis Excellence Forum Excellence Forum

Psoriatic Arthritis
Excellence Forum
Leaders in the field sharing authoritative insights and institutional best practices.

Vinod Chandran
Q&A
Vinod Chandran, MBBS, MD, on Depression, Anxiety, and Psoriatic Arthritis
10/28/2022
Dr Chandran reviewed the findings to date from his research into the impact of depression and anxiety on patients with psoriatic arthritis and how that can reduce the chances of achieving minimal disease activity.
Dr Chandran reviewed the findings to date from his research into the impact of depression and anxiety on patients with psoriatic arthritis and how that can reduce the chances of achieving minimal disease activity.
Dr Chandran reviewed the...
10/28/2022
Rheumatology & Arthritis
Saundra Jain
Q&A
Wellness in Rheumatic Diseases: A Conversation with Saundra Jain, MS, PsyD, and Andrew Laster, MD
09/30/2022
In this Q&A, Saundra Jain, MS, PsyD, and Andrew Laster, MD, discuss the concept of wellness in the context of rheumatic diseases and inflammatory arthritis.
In this Q&A, Saundra Jain, MS, PsyD, and Andrew Laster, MD, discuss the concept of wellness in the context of rheumatic diseases and inflammatory arthritis.
In this Q&A, Saundra Jain, MS,...
09/30/2022
Rheumatology & Arthritis
Len Calabrese
Commentary
Leonard Calabrese, DO, on Long COVID for the Rheumatologist
08/23/2022
 
Leonard Calabrese, DO
Vice Chairman, Department of Rheumatic and Immunologic Diseases
Head of the Section of Clinical Immunology
Cleveland Clinic Foundation, Cleveland, Ohio.

 

  Leonard Calabrese, DO Vice Chairm...
Dr Calabrese, from Cleveland Clinic, says rheumatologists should expect to see more cases of long-lasting effects from COVID-19.
Dr Calabrese, from Cleveland Clinic, says rheumatologists should expect to see more cases of long-lasting effects from COVID-19.
Dr Calabrese, from Cleveland...
08/23/2022
Rheumatology & Arthritis
Alexis Ogdie
Q&A
Alexis Ogdie, MD, on a Treat To Target Approach to Psoriatic Arthritis
06/29/2022
How beneficial is achieving minimal disease activity for patients with psoriatic arthritis? Alexis Ogdie, MD, of the University of Pennsylvania, answers some questions about her research into this subject in this Q&A.
How beneficial is achieving minimal disease activity for patients with psoriatic arthritis? Alexis Ogdie, MD, of the University of Pennsylvania, answers some questions about her research into this subject in this Q&A.
How beneficial is achieving...
06/29/2022
Rheumatology & Arthritis
Orbai
Q&A
PROMIS-29 Validated for Psoriatic Arthritis
05/16/2022
Ana-Maria Orbai, MD, answered our questions about her work in validating the PROMIS-29 instrument for use among patients with psoriatic arthritis.
Ana-Maria Orbai, MD, answered our questions about her work in validating the PROMIS-29 instrument for use among patients with psoriatic arthritis.
Ana-Maria Orbai, MD, answered...
05/16/2022
Rheumatology & Arthritis
Schwartzman
Q&A
Monica Schwartzman, MD, on Medication Preferences Among Patients with PsA
05/10/2022
Dr. Monica Schwartzman, from the Hospital for Special Surgery and New York Presbyterian Weill Cornell in New York City, answers our questions about a recent study on medication practices and preferences among patients with psoriatic arthritis.
Dr. Monica Schwartzman, from the Hospital for Special Surgery and New York Presbyterian Weill Cornell in New York City, answers our questions about a recent study on medication practices and preferences among patients with psoriatic arthritis.
Dr. Monica Schwartzman, from the...
05/10/2022
Rheumatology & Arthritis
Bath Institute for Rheumatic Diseases logo
Q&A
Bath Institute for Rheumatic Diseases on PsA Research and Education
04/27/2022
Celia Mead, executive director of BIRD, discusses how receiving the UPLIFT Innovation Challenge grant has helped support the organization's initiatives in funding psoriatic arthritis research, educating health care professionals, and running...
Celia Mead, executive director of BIRD, discusses how receiving the UPLIFT Innovation Challenge grant has helped support the organization's initiatives in funding psoriatic arthritis research, educating health care professionals, and running...
Celia Mead, executive director...
04/27/2022
Rheumatology & Arthritis
Vikas Majithia
Q&A
Vikas Majithia, MD, on Challenges in Diagnosing PsA
03/25/2022
Vikas Majithia, MD, from the Mayo Clinic in Jacksonville, Florida, shared his insights into the challenges of diagnosing psoriatic arthritis.
Vikas Majithia, MD, from the Mayo Clinic in Jacksonville, Florida, shared his insights into the challenges of diagnosing psoriatic arthritis.
Vikas Majithia, MD, from the...
03/25/2022
Rheumatology & Arthritis
Ari Polachek, MD
Q&As
Ari Polachek, MD, on Comparing Ultrasound and MRI for PsA
03/10/2022
Dr Polachek explains his recent research comparing ultrasound, magnetic resonance imaging, and radiography for detection of inflammatory lesions and destructive changes in psoriatic arthritis.
Dr Polachek explains his recent research comparing ultrasound, magnetic resonance imaging, and radiography for detection of inflammatory lesions and destructive changes in psoriatic arthritis.
Dr Polachek explains his recent...
03/10/2022
Rheumatology & Arthritis
Ogdie
Q&A
Alexis Ogdie, MD, on Treat-to-Target in Psoriatic Arthritis
02/22/2022
Dr Ogdie, from the University of Pennsylvania, shared her thoughts on how a treat-to-target approach for patients with psoriatic arthritis can help achieve minimal disease activity.
Dr Ogdie, from the University of Pennsylvania, shared her thoughts on how a treat-to-target approach for patients with psoriatic arthritis can help achieve minimal disease activity.
Dr Ogdie, from the University of...
02/22/2022
Rheumatology & Arthritis

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Stay in the Know

Rheumatology & Arthritis Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Partner Spotlight

Axial Involvement in SpA: A Patient-Centered Exploration, Chapter 1
SPONSORED
Axial Involvement in SpA, Chapter 1
04/26/2022
Ethan Craig, MD, MPH, discusses 3 of his patient cases to identify and differentiate axial involvement within the spectrum of SpA.
Ethan Craig, MD, MPH, discusses 3 of his patient cases to identify and differentiate axial involvement within the spectrum of SpA.
Ethan Craig, MD, MPH, discusses...
04/26/2022
Rheumatology & Arthritis

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Popular Articles

News
Interleukin Inhibitors Effective Among TNFi-Exposed Patients With PsA
05/16/2022
Investigators set out to determine if interleukin-17 and -12/23 inhibitors were effective among patients with psoriatic disease who responded inadequately to tumor necrosis factor inhibitors.
Investigators set out to determine if interleukin-17 and -12/23 inhibitors were effective among patients with psoriatic disease who responded inadequately to tumor necrosis factor inhibitors.
Investigators set out to...
05/16/2022
Rheumatology & Arthritis

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement